News

Scientists develop ‘Twitter’ for cells
10 January 2020
Computational biologists led by Yvan Saeys (VIB-UGent) developed new bioinformatics method to better study communication between cells. This helps researchers to gain insight into how the gene expression of cells is regulated by interacting cells.
New field trial with genetically modified maize
10 January 2020
VIB has submitted an application for a new field trial with genetically modified maize. The maize has been improved by additionally expressing a growth factor called "AN3" in the plants.
Diether Lambrechts receives ERC Proof of Concept grant
10 January 2020
Diether Lambrechts (VIB-KU Leuven Center for Cancer Biology) has been awarded a Proof of Concept grant by the European Research Council.
Understanding Charcot-Marie-Tooth disease
9 January 2020
Charcot–Marie–Tooth disease is a condition that affects the peripheral nervous system. It leads to progressive muscle weakness and loss of sensation in the limbs. It is commonly inheritable neuromuscular disorder and, at the moment, remains incurable.
CRISPR-Knockout
7 January 2020
A team from the VIB-UGent Center for Plant Systems Biology devised a CRISPR-based tissue-specific knockout system, CRISPR-TSKO, that enables the generation of somatic mutations in particular plant cell types, tissues, and organs.
Quickscan IV
7 January 2020
VIB's scientific publications of the last quarter 2019
VIB and KU Leuven announce new spin-off Augustine Therapeutics to fight neuromuscular diseases
16 December 2019
Today, VIB and KU Leuven present a new venture, Augustine Therapeutics, with the mission to develop innovative therapeutics for patients suffering from Charcot-Marie-Tooth disease. Augustine raises a seed-round of 4.2 million euro with.
Patients can be valuable partners in research
13 December 2019
To progress successfully in biomedical research, patients & researchers often need to collaborate actively. To guarantee a constructive relationship between all parties requires mutual respect and a balance between expectations of all parties.
Funding basic research - powering breakthroughs
13 December 2019
New medical treatments or improved therapies are often derived from novel insights in fundamental scientific research. Such research requires state-of-the-art equipment, talented personnel, specialized reagents and, potentially, rigorous safety testing.
Snapshot of our foundational funding
13 December 2019
Funding for scientific research is not easy to come by. At the same time, many foundations generously pledge significant amounts to scientists and research programs they believe can further their cause.
Resources via charity and foundations
13 December 2019
“The Charcot Research Fund allows us to test the broader impact of our basic research on different autoimmune diseases,in this case MS” - Rudi Beyaert (VIB-UGent Center for Inflammation Research)
From patients to practitioners to scientists, and back again: reversed science cafés
13 December 2019
For science to have maximum societal impact, the specific knowhow and experiences from different stakeholders, including patients and citizens besides researchers, academia, clinicians, industry, funders, government, should be better valued.
Local players and great supporters
13 December 2019
While big international funding initiatives might be the most eye-catching science funding sources, local foundations often play an equally pivotal role. They are often more in touch with the local scientific landscape and patients.
Alumni Kim Plasman, on the other side of research funding
13 December 2019
VIB alumna Kim Plasman is scientific director at the Stichting Alzheimer Onderzoek. Between 2008 and 2015, she worked at VIB-UGent Department of Medical Protein Research (now the VIB-UGent Center for Medical Biotechnology).
Jan Tavernier (VIB-UGent) in Top 20 Translational Researchers
12 December 2019
Jan Tavernier (VIB-UGent Center for Medical Biotechnology) is only the second Belgian ever to make it onto the US-dominated list. The list is an aggregate score of number of patents granted in that year, patent citations and h-index.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS